Kathryn Breaker

Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib

Julia Clemons, Dexiang Gao, Mary Naam et al. · Clinical Genitourinary Cancer · 2012 · 60 citations

Medicine, Endocrinology, Oncology +10

Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma

Thomas W. Flaig, Fernando J. Kim, Francisco G. La Rosa et al. · Investigational New Drugs · 2008 · 38 citations

Medicine, Oncology, Pharmacology +13

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib

Thomas W. Flaig, Luciano J. Costa, Daniel L. Gustafson et al. · British Journal of Cancer · 2010 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical significance of sunitinib‐associated macrocytosis in metastatic renal cell carcinoma

María T. Bourlon, Dexiang Gao, Sara Trigero et al. · Cancer Medicine · 2016 · 14 citations · Full text

Medicine, Oncology, Pharmacology +16

Pembrolizumab (pembro) and cabozantinib (cabo) in patients (pts) with metastatic renal cell carcinoma (mRCC): Phase I results.

Molika Emmeline Keeler, Elizabeth R. Kessler, Brandon Bernard et al. · Journal of Clinical Oncology · 2019 · 13 citations

Medicine, Oncology, Pharmacology +17